Paulus Stoffels
2014
In 2014, Paulus Stoffels earned a total compensation of $18.3M as CSO; Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, a 134% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,267,167 |
|---|---|
| Non-Equity Incentive Plan | $2,573,450 |
| Option Awards | $1,307,669 |
| Salary | $1,075,423 |
| Stock Awards | $10,690,520 |
| Other | $425,088 |
| Total | $18,339,317 |
Stoffels received $10.7M in stock awards, accounting for 58% of the total pay in 2014.
Stoffels also received $2.3M of change in pension value and nonqualified deferred compensation earnings, $2.6M in non-equity incentive plan, $1.3M in option awards, $1.1M in salary and $425.1K in other compensation.
Rankings
In 2014, Paulus Stoffels' compensation ranked 150th out of 13,032 executives tracked by ExecPay. In other words, Stoffels earned more than 98.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 150 out of 13,032 | 99th |
Division Manufacturing | 58 out of 4,967 | 99th |
Major group Chemicals And Allied Products | 25 out of 1,690 | 99th |
Industry group Drugs | 22 out of 1,369 | 98th |
Industry Pharmaceutical Preparations | 20 out of 1,042 | 98th |
Source: SEC filing on March 11, 2015.
Stoffels' colleagues
We found four more compensation records of executives who worked with Paulus Stoffels at Johnson & Johnson in 2014.